(VOVWORLD) – The Standing Board of the National Steering Committee for COVID-19 Prevention and Control has agreed to create the best possible conditions for the trial of homegrown vaccines.
If the trial goes well, in the context of vaccine scarcity the Ministry of Health will submit to competent agencies for approval of the use of homegrown vaccines in emergency circumstances.
Several companies have invested in plants and are seeking vaccine production technologies both in and outside the country. At least one large-scale COVID-19 vaccine production plant is scheduled to be put in operation in late 2021 or early 2022. The Ministry of Health has urged the Company for Vaccine and Biological Production No.1 (VABIOTECH) to conduct procedures to receive Sputnik V vaccine production technology from Russia in two phases. In the first phase, the company will import materials from Russia for bottling and production is expected to begin in July.